The total return over the past 12 months is -12.78% vs. +16.94% for the S&P 500. So far it's up +94.78% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (12.78%) | +3.68% | N/A | N/A | N/A | N/A |
| Total Return CAGR | (12.78%) | +3.68% | N/A | N/A | N/A | N/A |
| Revenue CAGR | +291.42% | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Pyxis Oncology, Inc. (PYXS)
| Year | Start price | End price | PYXS Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.15 | $2.24 | +94.78% | +14.51% | +80.27% |
| 2025 | $1.56 | $1.15 | (26.28%) | +17.72% | (44.00%) |
| 2024 | $1.80 | $1.56 | (13.33%) | +24.89% | (38.22%) |
| 2023 | $1.34 | $1.80 | +34.33% | +26.19% | +8.14% |
| 2022 | $10.97 | $1.34 | (87.78%) | (18.17%) | (69.61%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
